SCHEMBL2554972

SCHEMBL2554972

CC(=CC=O)c1ccccn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.57
▸ CES2 O00748 1/20 0.50
▸ CES1 P23141 1/20 0.50
▸ KDM4E B2RXH2 3/20 0.48
▸ LMNA P02545 3/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ NAPRT Q6XQN6 1/20 0.48
▸ P4HTM Q9NXG6 1/20 0.48
▸ KMT2A Q03164 1/20 0.44
▸ GSK3B P49841 1/20 0.43
▸ MAPK1 P28482 1/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ TOP2A P11388 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HTT P42858 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2554971 1.00 ALDH1A1 (0.57) ALDH1A1CES2CES1KDM4ELMNA
SCHEMBL19480611 0.82 ALDH1A1 (0.53) ALDH1A1CES2CES1KDM4ELMNA
SCHEMBL18410851 0.81 ALDH1A1 (0.52) ALDH1A1CES2CES1KDM4ELMNA
SCHEMBL10465175 0.81 ALDH1A1 (0.52) ALDH1A1CES2CES1KDM4ELMNA
SCHEMBL19039480 0.81 ALDH1A1 (0.52) ALDH1A1CES2CES1KDM4ELMNA
SCHEMBL3729713 0.79 ALDH1A1 (0.59) ALDH1A1CES2CES1KDM4ELMNA
SCHEMBL3729714 0.79 ALDH1A1 (0.59) ALDH1A1CES2CES1KDM4ELMNA
SCHEMBL9160142 0.79 ALDH1A1 (0.59) ALDH1A1CES2CES1KDM4ELMNA
SCHEMBL21279978 0.79 ALDH1A1 (0.50) ALDH1A1CES2CES1KDM4ELMNA
SCHEMBL20824986 0.79 ALDH1A1 (0.50) ALDH1A1CES2CES1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059040-A1 MUTANT KRAS MODULATORS AND USES THEREOF NEWAVE PHARMACEUTICAL INC. (US) 2025-03-20 — — WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 — — US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 — — US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 — — EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 — — EP disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 — — US disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 — — EP disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 — — WO disclosed
Send feedback